Yoshizaki, Hiroyuki <br/><br/>
[Pharmacological profile of human-type anti-CD20 antibody ofatumumab (Arzerra(®)) and its clinical study results].  [electronic resource] 

 -  Nihon yakurigaku zasshi. Folia pharmacologica Japonica  Jan 2014 
 - 40-3 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>0015-5691 
<br/><br/><label>Standard No.: </label>10.1254/fpj.143.40  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Humanized<br/>Antibody-Dependent Cell Cytotoxicity--drug effects<br/>Antigens, CD20--immunology<br/>Antineoplastic Agents--administration & dosage<br/>Clinical Trials, Phase I as Topic<br/>Clinical Trials, Phase II as Topic<br/>Complement System Proteins--immunology<br/>Disease Models, Animal<br/>Humans<br/>Japan<br/>Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy<br/>Republic of Korea